Supporting material "Acquired Willebrand syndrome during continuous or pulsatile extracorporeal carbon dioxide removal"

Two consecutive prospective monocentric observational ECCO2R studies (NCT 02965079 and 05079009) were conducted involving the Hemolung (Hemolung Group 1, n=8) and iLA Activve (iLA-continuous Group 2, n=12) devices under continuous extracorporeal blood flow and the iLA Activve device set to the “Advanced” mode (iLA-pulsatile Group 3, n=6), allowing a pulsatile extracorporeal flow. Since some baseline imbalances were observed, adjusted analyses were performed and are presented as supporting material in Mendeley Data

两项连续性前瞻性单中心观察性体外二氧化碳清除（ECCO2R，Extracorporeal Carbon Dioxide Removal）研究（临床试验编号：NCT 02965079与NCT 05079009）已完成。本研究涉及三类实验分组：第一组使用Hemolung装置（Hemolung组，n=8）；第二组采用持续性体外血流模式，应用iLA Activve设备（iLA连续组，n=12）；第三组将iLA Activve设备设置为"Advanced"高级模式，支持搏动性体外血流（iLA搏动组，n=6）。鉴于研究中观察到部分基线失衡情况，本研究开展了校正分析，相关结果作为补充材料已上传至Mendeley Data平台。